FIELD: biotechnology, genetic engineering, pharmacy. SUBSTANCE: invention relates to human protein neurotropin-3 (NT-3) by culturing mammalian cells transformed by an expression vector that contains the isolated DNA fragment encoding the indicated protein. Isolated DNA fragment involves a nucleotide sequence that encodes a precursor of human neurotropin-3 consisting of an amino acid sequence splitting by protease and the following amino acid sequence of matured protein neurotropin-3. Protein NT-3 has a molecular mass 14 kDa, it is able to initiate survival, growth or differentiation of neurons, intergrowing nodular and dorsal ganglions from radices. A pharmaceutical composition is obtained that has protein NT-3 as an active component taken at therapeutically effective dose and a pharmaceutically acceptable carrier. Obtained protein NT-3 can be used for diagnosis and treatment of patients with different neurological disorders. EFFECT: improved of protein preparing. 5 cl, 45 dwg, 6 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
DNA-FRAGMENT ENCODING BRAIN NEUROTROPIC FACTOR (BDNF), BDNF PROTEIN AND METHOD OF ITS PREPARING | 1990 |
|
RU2131926C1 |
METHOD OF SYNTHESIS OF POLYPEPTIDE, HYBRID DNA (VARIANTS), FUSION PROTEIN (VARIANTS) | 1991 |
|
RU2120475C1 |
RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) WITHOUT ADDITIONAL METHIONINE RESIDUE AT N-TERMINUS | 1991 |
|
RU2108386C1 |
MUTANT CHANNEL RHODOPSIN-2 | 2011 |
|
RU2595384C2 |
SMALL RNA MOLECULES, MEDIATING RNA INTERFERENCE | 2007 |
|
RU2470073C2 |
SMALL RNA MOLECULES MEDIATING RNA INTERFERENCE | 2001 |
|
RU2322500C2 |
PROMOTER FOR SPECIFIC TRANSGENE EXPRESSION IN PLANT EPIDERMIS | 2004 |
|
RU2382079C2 |
DNA (VARIANTS), METHOD FOR PREPARING PROTEIN, PROTEIN, PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2208638C2 |
METHOD OF PRODUCING SAMPLE IMAGE | 2014 |
|
RU2662461C2 |
TUBERCULOSIS VACCINE WITH IMPROVED STRENGTH | 2004 |
|
RU2342400C2 |
Authors
Dates
1999-03-27—Published
1990-08-29—Filed